Drug package

- Amicus Therapeutics, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains atleast one drawing executed in color. Copies of this patent with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a top, side perspective view of a first embodiment of a drug package;

FIG. 2 is a front view of a first embodiment of a drug package;

FIG. 3 is a top view of a first embodiment of a drug package;

FIG. 4 is a bottom view of a first embodiment of a drug package;

FIG. 5 is a top, side perspective view of a second embodiment of a drug package;

FIG. 6 is a front view of a second embodiment of a drug package;

FIG. 7 is a top view of a second embodiment of a drug package;

FIG. 8 is a bottom view of a second embodiment of a drug package;

FIG. 9 is a front top perspective view of a third embodiment of a drug package;

FIG. 10 is a front view of a third embodiment of a drug package;

FIG. 11 is a top view of a third embodiment of a drug package;

FIG. 12 is a bottom view of a third embodiment of a drug package;

FIG. 13 is a top, side perspective view of a fourth embodiment of a drug package;

FIG. 14 is a front view of a fourth embodiment of a drug package;

FIG. 15 is a top view of a fourth embodiment of a drug package;

FIG. 16 is a bottom view of a fourth embodiment of a drug package;

FIG. 17 is a top, side perspective view of a fifth embodiment of a drug package;

FIG. 18 is a front view of a fifth embodiment of a drug package;

FIG. 19 is a top view of a fifth embodiment of a drug package;

FIG. 20 is a bottom view of a fifth embodiment of a drug package;

FIG. 21 is a front top perspective view of a sixth embodiment of a drug package;

FIG. 22 is a front view of a sixth embodiment of a drug package;

FIG. 23 is a top view of sixth embodiment of a drug package; and,

FIG. 24 is a bottom view of a sixth embodiment of a drug package.

The broken lines shown in the drawings are for the purpose of illustrating parts of the article that form no part of the claimed design.

Claims

The ornamental design for a drug package, as shown and described.

Referenced Cited
U.S. Patent Documents
RE33503 December 25, 1990 Schluger et al.
D539645 April 3, 2007 Chen et al.
D546694 July 17, 2007 Penfold
D586210 February 10, 2009 Noschang
D610451 February 23, 2010 Rippe
D612234 March 23, 2010 Westemeyer
D622609 August 31, 2010 Partin
D660145 May 22, 2012 Tekulve
D686067 July 16, 2013 Macaulay
D713726 September 23, 2014 Denham
D752439 March 29, 2016 Abel et al.
D753487 April 12, 2016 Wells et al.
D765505 September 6, 2016 Rubio
D779935 February 28, 2017 Rotar et al.
D787331 May 23, 2017 Sims et al.
D794442 August 15, 2017 Boston et al.
D799964 October 17, 2017 Abel et al.
D813888 March 27, 2018 Kim et al.
D822059 July 3, 2018 Connor et al.
D862223 October 8, 2019 Camper
D871203 December 31, 2019 Koeppel et al.
D871210 December 31, 2019 Clifton et al.
D879602 March 31, 2020 Ahlgren
D880293 April 7, 2020 Redding et al.
D883087 May 5, 2020 Riffe
D883088 May 5, 2020 Riffe et al.
D896640 September 22, 2020 Riffe
D912507 March 9, 2021 Caicedo et al.
D955878 June 28, 2022 Riffe
D973488 December 27, 2022 Johnson
D1014246 February 13, 2024 Lee et al.
D1030473 June 11, 2024 Fang
D1031431 June 18, 2024 Zhao et al.
20230050502 February 16, 2023 Donar, Jr.
Foreign Patent Documents
008843742-0001 January 2022 EP
008843742-0002 January 2022 EP
008843742-0003 January 2022 EP
008843742-0004 January 2022 EP
008843742-0005 January 2022 EP
008843742-0006 January 2022 EP
WO-2018063179 April 2018 WO
Other references
  • Nutricost Vitamin B12 Reviews (2023)—Miami Herald. Date posted:Aug. 3, 2023. Site visited: Sep. 2, 2023. Available online: https://www.miamiherald.com/reviews/nutricost-vitamin-b12/ (Year: 2023).
  • Amazon.com: Irofol High Potency Liquid Iron Dietary Supplement. Date first available: Dec. 4, 2013. Site visited; Sep. 2, 2023. Available online: https://www.amazon.com/dp/B00GN0FFWO/ref=sspa_dk_detail_3 (Year: 2013).
  • Pombiliti_ Package Insert, posted at Drugs.com (date not available) , [site visited Mar. 28, 2024]. Available from internet, URL: < https//www.drugs.com/pro/pombiliti.html> (Year: NA).
  • Pombiliti Amicus Therapeutics, posted at ir.amicusrx.com (date not available), [site visited Mar. 28, 2024]. Available from internet, URL: < https://ir.amicusrx.com/static-files/fc2d3ec7-2dbf-422b-8ef5-743cfa197870> (Year: NA).
  • “Opfolda—SmPC”, 25 pgs, Jun. 2023.
  • “Opfolda US Label”, 21 pgs, Sep. 2023.
  • “POMBILITI—SmPC”, 37 pgs. Mar. 2023.
  • “Pombiliti US Label”, 24 pgs, Sep. 2023.
Patent History
Patent number: D1082532
Type: Grant
Filed: Jul 30, 2021
Date of Patent: Jul 8, 2025
Assignee: Amicus Therapeutics, Inc. (Philadelphia, PA)
Inventors: Sameeha Hussein (Philadelphia, PA), Timothy Pribilski (Philadelphia, PA)
Primary Examiner: Catherine S Posthauer
Assistant Examiner: Joan E. Diehl
Application Number: 29/801,766
Classifications
Current U.S. Class: D9/529